GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (LTS:0RD1) » Definitions » FCF Margin %

Camurus AB (LTS:0RD1) FCF Margin % : 7.38% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Camurus AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Camurus AB's Free Cash Flow for the three months ended in Dec. 2023 was kr28 Mil. Camurus AB's Revenue for the three months ended in Dec. 2023 was kr375 Mil. Therefore, Camurus AB's FCF Margin % for the quarter that ended in Dec. 2023 was 7.38%.

As of today, Camurus AB's current FCF Yield % is 2.08%.

The historical rank and industry rank for Camurus AB's FCF Margin % or its related term are showing as below:

LTS:0RD1' s FCF Margin % Range Over the Past 10 Years
Min: -565.37   Med: -48.39   Max: 34.76
Current: 34.76


During the past 13 years, the highest FCF Margin % of Camurus AB was 34.76%. The lowest was -565.37%. And the median was -48.39%.

LTS:0RD1's FCF Margin % is ranked better than
95.37% of 1037 companies
in the Biotechnology industry
Industry Median: -147.18 vs LTS:0RD1: 34.76


Camurus AB FCF Margin % Historical Data

The historical data trend for Camurus AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB FCF Margin % Chart

Camurus AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -407.43 -72.07 -24.70 10.38 34.76

Camurus AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.72 7.89 9.25 126.14 7.38

Competitive Comparison of Camurus AB's FCF Margin %

For the Biotechnology subindustry, Camurus AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Camurus AB's FCF Margin % falls into.



Camurus AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Camurus AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=596.751/1716.85
=34.76 %

Camurus AB's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=27.625/374.566
=7.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Camurus AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Camurus AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB (LTS:0RD1) Business Description

Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032, and others. The company's geographical revenue includes Europe (of which Sweden), the United States of America, Australia, and Other geographical areas.

Camurus AB (LTS:0RD1) Headlines

No Headlines